Clinical trial
A Randomised Double Blind Study of the Effects of Homocysteine Lowering Therapy on Mortality and Cardiac Events in Patients Undergoing Coronary Angiography
NCT00354081 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Double Blind Study of the Effects of Homocysteine Lowering Therapy on Mortality and Cardiac Events in Patients Undergoing Coronary Angiography
- Lead sponsor
- Haukeland University Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 1999
- Completion date
- February 29, 2008
- Enrollment
- 3,096 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cerebrovascular stroke, coronary artery disease, myocardial infarction